Market Place
Sourcing Support
Amneal Launches First Two Respiratory Metered-Dose Inhalers in US
14 Apr 2026 //
GLOBENEWSWIRE
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
09 Apr 2026 //
GLOBENEWSWIRE
Amneal Wins FDA Approval for Epinephrine Injection Vials
09 Dec 2025 //
GLOBENEWSWIRE
Amneal Gets FDA Nod For Albuterol Sulfate Inhalation Aerosol
02 Dec 2025 //
GLOBENEWSWIRE
Amneal Gets FDA Nod For Albuterol Sulfate Inhaler
02 Dec 2025 //
GLOBENEWSWIRE
Amneal Gets FDA Nod For Cyclosporine Ophthalmic Emulsion 0.05%
01 Dec 2025 //
GLOBENEWSWIRE
Amneal Receives U.S. FDA Approval For Iohexol Injection
13 Nov 2025 //
GLOBENEWSWIRE
Amneal Gets FDA Tentative Approval For Beclomethasone Aerosol
29 Oct 2025 //
GLOBENEWSWIRE
Amneal Gets FDA Nod For Bimatoprost Ophthalmic Solution 0.01%
23 Sep 2025 //
GLOBENEWSWIRE
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
11 Sep 2025 //
GLOBENEWSWIRE
Amneal Gets Approval for Risperidone Extended-Release Injection
04 Sep 2025 //
GLOBENEWSWIRE
Girard Sharp and Motley Rice Announce Proposed Settlement
27 May 2025 //
PR NEWSWIRE
Amneal Launches Mesalamine, Gets FDA Nod For Lenalidomide
19 Feb 2025 //
BUSINESSWIRE
Amneal Wins FDA Nod for GLP-1 Generic
22 Nov 2024 //
BIOSPACE
Amneal Resubmits DHE Autoinjector NDA; FDA Approves Exenatide
22 Nov 2024 //
BUSINESSWIRE
Amneal asks court to block Colorado`s free allergy pen program
23 Sep 2024 //
REUTERS
Amneal’s Early Win Delists Five Teva Orange Book Inhaler Patents
11 Jun 2024 //
BLOOMBERGLAW
Amneal gains FDA greenlight to develop Ciprodex generic for ear infections
26 Mar 2024 //
PHARMACEUTICAL TECHNOLOGY
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
10 Jan 2024 //
BUSINESSWIRE
Amneal Submits Abbreviated NDA to U.S. FDA for Three Key Complex Generics
26 Jul 2023 //
BUSINESSWIRE
Amneal Launches Authorized Generic for Xyrem
03 Jul 2023 //
BUSINESSWIRE
Amneal Receives Abbreviated New Drug Application Approval Lidocaine Patch, 5%
25 Aug 2020 //
PRESS RELEASE
Amneal announces acquisition of 65.1% majority interest of generics, AvKARE
16 Dec 2019 //
IN-PHARMATECHNOLOGIST
Pfizer`s Lyrica market share crumbles under generic onslaught
20 Aug 2019 //
FIERCE PHARMA
Amneal’s Bisaro, CEO out as generics falter—Chutes & Ladders
09 Aug 2019 //
FIERCE BIOTECH
FDA greenlights nine Lyrica generics
25 Jul 2019 //
IN-PHARMATECHNOLOGIST
Tecfidera (Dimethyl Fumarate) : Biogen vs. Accord Healthcare
14 Feb 2019 //
PATENT LITIGATION
Restasis (Cyclosporine) : Allergan vs. Amneal Pharmaceuticals
30 Jan 2019 //
PATENT LITIGATION
Prezista (darunavir) : Janssen Sc. Ireland vs. Amneal Pharma
20 Dec 2018 //
PATENT LITIGATION
Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
10 Dec 2018 //
PATENT LITIGATION
Amneal Wins First Priority Review ANDA Approval
31 Oct 2018 //
RAPS
Yonsa (Abiraterone Acetate) : Sun Pharmaceutical vs. Teva Pharmaceuticals
19 Oct 2018 //
PATENT LITIGATION
Restasis (Cyclosporine) : Allergan vs. Amneal Pharmaceuticals
22 Sep 2018 //
PATENT LITIGATION
Restasis (Cyclosporine) : Allergan & St Regis Mohawk Tribe vs. Amneal Pharma
22 Sep 2018 //
PATENT LITIGATION
Linezolid : Symed Labs, Hetero USA vs. Amneal Pharmaceuticals
15 Sep 2018 //
PATENT LITIGATION
Linezolid : Symed Labs & Hetero USA v. Amneal Pharmaceuticals
06 Sep 2018 //
PATENT LITIGATION
Amneal obtains non-infringement finding in Sensipar case
02 Aug 2018 //
LIFESCIENCE PREVIEW
Amneal Announces FDA Approval & Launch of Generic Potassium Chloride
23 Jul 2018 //
PR NEWSWIRE
U.S. court denies Jazz Pharma bid to revive patents on narcolepsy drug
13 Jul 2018 //
REUTERS
FTC imposes conditions on Amneal acquisition of Impax
11 Jul 2018 //
PHARMA LETTER
OTEZLA® (apremilast): Celgene Corporation v. Amneal Pharmaceuticals Llc
04 Jul 2018 //
PATENT LITIGATION
Cialis® (Tadalafil) : Eli Lilly And Company v Amneal Pharmaceuticals
10 May 2018 //
PATENT LITIGATION
Farxiga® (Estradiol ): Noven Pharmaceuticals, v. Amneal Pharmaceuticals
08 May 2018 //
PATENT LITIGATION
ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax
07 May 2018 //
PR NEWSWIRE
Amneal Launches Generic for Sabril®: Vigabatrin for Oral Solution, USP
02 May 2018 //
PR NEWSWIRE
U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
01 May 2018 //
REUTERS
ANI Pharma`s Signs Agreements to Acquire Generic Products from Amneal/Impax
27 Apr 2018 //
PR NEWSWIRE
Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals
05 Apr 2018 //
PATENT LITIGATION
Amneal Launches Methylphenidate HCl Extended-Release Tablets, USP (CII)
05 Feb 2018 //
PR NEWSWIRE
Opsumit (Macitentan): Actelion Pharmaceuticals v. Zydus Pharmaceuticals (USA)
31 Jan 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Amneal Pharmaceuticals
30 Jan 2018 //
PATENT LITIGATION
FDA Denies Amneal Petition Seeking to Block Generic Versions of Osteoporosis
09 Jan 2018 //
RAPS
Bisaro, Amneal poach top Allergan exec for CEO`s chair
19 Dec 2017 //
FIERCE PHARMA
Endo could be the next generics player hunting for M&A: analyst
04 Oct 2017 //
FIERCE PHARMA
Impax CEO Bisaro reportedly putting his M&A moves on Amneal
23 Sep 2017 //
FIERCE PHARMA
AstraZeneca, Amneal Settle Generic Diabetes Drug Fight
19 Sep 2017 //
LAW360
Copaxone® (Glatiramer Acetate): Teva Pharmaceuticals V.Amneal Pharmaceuticals
20 Jul 2017 //
PATENT LITIGATION
Zithromax® (Azithromycin): Amneal Pharmaceuticals V. Pfizer Inc
20 Apr 2017 //
PATENT LITIGATION
Velcade (Bortezomib): Millennium Pharmaceuticals v. Amneal Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Amitiza (Lubiprostone): Sucampo & Takeda v. Amneal Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
